Production of recombinant proteins from protozoan parasites

Trends in Parasitology

Volumn 26, Issue 5, 2010, Pages 244-254

  Fernández Robledo, José A ^a   Vasta, Gerardo R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; RECOMBINANT VACCINE; DIAGNOSTIC AGENT; PROTOZOAL PROTEIN; PROTOZOAL VACCINE;

BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; DNA SEQUENCE; EXPRESSION VECTOR; GENE EXPRESSION SYSTEM; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; PARASITE; PHYLOGENY; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTISTAN COMMUNITY; REVIEW; YEAST; BIOSYNTHESIS; CELL FREE SYSTEM; EUKARYOTE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; PROKARYOTIC CELL;

PROTOZOA;

CELL-FREE SYSTEM; EUKARYOTA; GENE EXPRESSION; PROKARYOTIC CELLS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS;

EID: 77956398026     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2010.02.004     Document Type: Review

References (88)

1. de Azevedo W.F., Soares M.B. Selection of targets for drug development against protozoan parasites. Curr. Drug Targets 2009, 10:193-201.
2. Coombs A. The sequencing shakeup. Nat. Biotechnol. 2008, 26:1109-1112.
3. Greenwood B.M., et al. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest. 2008, 118:1266-1276.
4. Murray C.K., Bennett J.W. Rapid diagnosis of malaria. Interdiscip. Perspect. Infect. Dis. 2009, 2009:415953.
5. Seitzer U., et al. Evaluation of Theileria annulata recombinant immunodominant proteins for the development of ELISA. Transbound. Emerg. Dis. 2008, 55:244-248.
6. Lee N., et al. Effect of sequence variation in Plasmodium falciparum histidine-rich protein 2 on binding of specific monoclonal antibodies: implications for rapid diagnostic tests for malaria. J. Clin. Microbiol. 2006, 44:2773-2778.
7. Anon. (2008) International meeting: new diagnostic tests are urgently needed to treat patients with Chagas disease. Rev. Soc. Bras. Med. Trop. 41, 315-319.
8. Hunfeld K.P., et al. Babesiosis: recent insights into an ancient disease. Int. J. Parasitol. 2008, 38:1219-1237.
9. Neuber H. Leishmaniasis. J. Dtsch. Dermatol. Ges. 2008, 6:754-765.
10. Ripley Ballou W. Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine. Microbes Infect. 2007, 9:761-766.
11. Fatumo S., et al. Estimating novel potential drug targets of Plasmodium falciparum by analysing the metabolic network of knock-out strains in silico. Infect. Genet. Evol. 2009, 9:351-358.
12. Awale M., et al. Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors. J. Mol. Model. 2009, 16:475-488.
13. Wiesner J., et al. The plastid-like organelle of apicomplexan parasites as drug target. Curr. Pharm. Des. 2008, 14:855-871.
14. Morgan R.E., et al. Inhibitors of tubulin assembly identified through screening a compound library. Chem. Biol. Drug Des. 2008, 72:513-524.
15. Chen X., et al. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:14548-14553.
16. Joachimiak A. High-throughput crystallography for structural genomics. Curr. Opin. Struct. Biol. 2009, 19:573-584.
17. Patel V., et al. Identification and characterization of small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. J. Biol. Chem. 2008, 283:35078-35085.
18. Hillier C.J., et al. Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. Infect. Immun. 2005, 73:2109-2115.
19. Arnot D.E., et al. Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum. Clin. Vaccine Immunol. 2008, 15:1345-1355.
20. Qian F., et al. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates. Vaccine 2007, 25:3923-3933.
21. Cai Q., et al. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Vaccine 2007, 25:5155-5165.
22. Lau Y.L., Fong M.Y. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris. Exp. Parasitol. 2008, 119:373-378.
23. Luk F.C., et al. N-linked glycosylation of proteins in the protozoan parasite Toxoplasma gondii. Mol. Biochem. Parasitol. 2008, 157:169-178.
24. Maier A., Steverding D. Expression and purification of non-glycosylated Trypanosoma brucei transferrin receptor in insect cells. Exp. Parasitol. 2008, 120:205-207.
25. Miao J., et al. The malaria parasite Plasmodium falciparum histones: organization, expression, and acetylation. Gene 2006, 369:53-65.
26. Saksouk N., et al. Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii. Mol. Cell. Biol. 2005, 25:10301-10314.
27. Birkholtz L.M., et al. Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar. J. 2008, 7:197.
28. Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 2006, 72:211-222.
29. Vedadi M., et al. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol. Biochem. Parasitol. 2007, 151:100-110.
30. Mehlin C., et al. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol. Biochem. Parasitol. 2006, 148:144-160.
31. Aguiar J.C., et al. High-throughput generation of Plasmodium falciparum functional molecules by recombinational cloning. Genome Res. 2004, 14:2076-2082.
32. Graslund S., et al. Protein production and purification. Nat. Methods 2008, 5:135-146.
33. Caspeta L., et al. The effect of heating rate on Escherichia coli metabolism, physiological stress, transcriptional response, and production of temperature-induced recombinant protein: a scale-down study. Biotechnol. Bioeng. 2009, 102:468-482.
34. Crowther G.J., et al. Buffer optimization of thermal melt assays of Plasmodium proteins for detection of small-molecule ligands. J. Biomol. Screen. 2009, 14:700-707.
35. Sahdev S., et al. Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol. Cell. Biochem. 2008, 307:249-264.
36. Baca A.M., Hol W.G. Overcoming codon bias: a method for high-level overexpression of Plasmodium and other AT-rich parasite genes in Escherichia coli. Int. J. Parasitol. 2000, 30:113-118.
37. Gibson D.G., et al. Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science 2008, 319:1215-1220.
38. Welch M., et al. Design parameters to control synthetic gene expression in Escherichia coli. PLoS One 2009, 4:e7002.
39. Na B.K., et al. Cryptopain-1, a cysteine protease of Cryptosporidium parvum, does not require the pro-domain for folding. Parasitology 2009, 136:149-157.
40. Quintas-Granados L.I., et al. Purification, refolding and autoactivation of the recombinant cysteine proteinase EhCP112 from Entamoeba histolytica. Protein Expr. Purif. 2009, 63:26-32.
41. Aboge G.O., et al. Cloning, expression, and characterization of Babesia gibsoni dihydrofolate reductase-thymidylate synthase: inhibitory effect of antifolates on its catalytic activity and parasite proliferation. Antimicrob. Agents Chemother. 2008, 52:4072-4080.
42. Schmidt N.W., et al. CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge. Vaccine 2009, 27:6103-6106.
43. Makrides S.C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 1996, 60:512-538.
44. LaCount D.J., et al. A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 2005, 438:103-107.
45. Shrestha B., et al. Baculovirus expression vector system: an emerging host for high-throughput eukaryotic protein expression. Methods Mol. Biol. 2008, 439:269-289.
46. Wang Y., et al. Expression, purification and characterization of recombinant mitochondrial topoisomerase II of kinetoplastid Crithidia fasciculata in high-five insect cells. Protein Expr. Purif. 2008, 58:122-131.
47. Birkett A., et al. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect. Immun. 2002, 70:6860-6870.
48. Walther M., et al. Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein. Infect. Immun. 2006, 74:2706-2716.
49. Bonaldo M.C., et al. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. J. Mol. Biol. 2002, 315:873-885.
50. Pang A.L., et al. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system. Infect. Immun. 2002, 70:2772-2779.
51. Draper S.J., et al. Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria. Cell Host Microbe 2009, 5:95-105.
52. Caetano B.C., et al. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice. Hum. Gene Ther. 2006, 17:415-426.
53. Roque-Resendiz J.L., et al. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis. Parasitology 2004, 128:397-405.
54. Gaertig J., et al. Surface display of a parasite antigen in the ciliate Tetrahymena thermophila. Nat. Biotechnol. 1999, 17:462-465.
55. Clark T.G., et al. The I-antigens of Ichthyophthirius multifiliis are GPI-anchored proteins. J. Eukaryot. Microbiol. 2001, 48:332-337.
56. Peterson D.S., et al. The circumsporozoite protein of Plasmodium falciparum is expressed and localized to the cell surface in the free-living ciliate Tetrahymena thermophila. Mol. Biochem. Parasitol. 2002, 122:119-126.
57. Weide T., et al. A recombinase system facilitates cloning of expression cassettes in the ciliate Tetrahymena thermophila. BMC Microbiol. 2007, 7:12.
58. Eisen J.A., et al. Macronuclear genome sequence of the ciliate Tetrahymena thermophila, a model eukaryote. PLoS Biol. 2006, 4:e286.
59. Muller-Taubenberger A., Bozzaro S. From cell-cell adhesion and cellular oscillations to spectacular views inside the cell - 50 years of research with Dictyostelium. Eur. J. Cell Biol. 2006, 85:851-858.
60. Arya R., et al. Dictyostelium discoideum - a promising expression system for the production of eukaryotic proteins. FASEB J. 2008, 22:4055-4066.
61. Reymond C.D., et al. Anchoring of an immunogenic Plasmodium falciparum circumsporozoite protein on the surface of Dictyostelium discoideum. J. Biol. Chem. 1995, 270:12941-12947.
62. Fasel N., et al. Dictyostelium discoideum as an expression host for the circumsporozoite protein of Plasmodium falciparum. Gene 1992, 111:157-163.
63. Eichinger L., et al. The genome of the social amoeba Dictyostelium discoideum. Nature 2005, 435:43-57.
64. Asahi H. Plasmodium falciparum: chemically defined medium for continuous intraerythrocytic growth using lipids and recombinant albumin. Exp. Parasitol. 2009, 121:22-28.
65. Suresh P., Rehg J.E. Comparative evaluation of several techniques for purification of Cryptosporidium parvum oocysts from rat feces. J. Clin. Microbiol. 1996, 34:38-40.
66. Howe D.K., et al. Expression of Toxoplasma gondii genes in the closely-related apicomplexan parasite Neospora caninum. Mol. Biochem. Parasitol. 1997, 86:29-36.
67. Ramirez J.R., et al. Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice. Vaccine 2001, 20:455-461.
68. Kucknoor A.S., et al. Heterologous expression in Tritrichomonas foetus of functional Trichomonas vaginalis AP65 adhesin. BMC Mol. Biol. 2005, 6:5.
69. Sa J.M., et al. Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum. Mol. Biochem. Parasitol. 2006, 150:219-228.
70. Carrillo C., et al. Trypanosoma cruzi as a model system to study the expression of exogenous genes coding for polyamine biosynthetic enzymes. Induction of DFMO resistance in transgenic parasites. Biochim. Biophys. Acta 2007, 1770:1605-1611.
71. Mudeppa D.G., et al. Cell-free production of functional Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Mol. Biochem. Parasitol. 2007, 151:216-219.
72. Tsuboi T., et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect. Immun. 2008, 76:1702-1708.
73. Leander B.S., Keeling P.J. Morphostasis in alveolate evolution. Trends Ecol. Evol. 2003, 18:395-402.
74. Saldarriaga J.F., et al. Multiple protein phylogenies show that Oxyrrhis marina and Perkinsus marinus are early branches of the dinoflagellate lineage. Int. J. Syst. Evol. Microbiol. 2003, 53:355-365.
75. Gauthier J.D., et al. Effect of fetal bovine serum glycoproteins on the in vitro proliferation of the oyster parasite Perkinsus marinus: development of a fully defined medium. J. Eukaryot. Microbiol. 1995, 42:307-313.
76. La Peyre J.F., Faisal M. Development of a protein-free chemically defined culture medium for the propagation of the oyster pathogen Perkinsus marinus. Parasite 1997, 4:67-73.
77. Fernández-Robledo J.A., et al. Transfection of the protozoan parasite Perkinsus marinus. Mol. Biochem. Parasitol. 2008, 157:44-53.
78. Keeling P.J. Evolutionary biology: bridge over troublesome plastids. Nature 2008, 451:896-897.
79. Moore R.B., et al. A photosynthetic alveolate closely related to apicomplexan parasites. Nature 2008, 451:959-963.
80. Raja R., et al. A perspective on the biotechnological potential of microalgae. Crit. Rev. Microbiol. 2008, 34:77-88.
81. Graf A., et al. Yeast systems biotechnology for the production of heterologous proteins. FEMS Yeast Res. 2009, 9:335-348.
82. Wallbanks K.R., et al. The identity of Leishmania tarentolae Wenyon 1921. Parasitology 1985, 90:67-78.
83. Esposito D., et al. Gateway cloning for protein expression. Methods Mol. Biol. 2009, 498:31-54.
84. Hartley J.L. Use of the gateway system for protein expression in multiple hosts. Curr. Protoc. Protein Sci. 2003, Chapter 5, Unit 5.17.
85. Hartley J.L., et al. DNA cloning using in vitro site-specific recombination. Genome Res. 2000, 10:1788-1795.
86. Haddad D., et al. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect. Immun. 2004, 72:1594-1602.
87. Abhyankar M.M., et al. Development of the Gateway system for cloning and expressing genes in Entamoeba histolytica. Parasitol. Int. 2009, 58:95-97.
88. Delbecq S., et al. Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against apicomplexan Babesia divergens. Vaccine 2006, 24:613-621.